Privia Health Group (NASDAQ:PRVA) Given Buy Rating at Needham & Company LLC

Needham & Company LLC reaffirmed their buy rating on shares of Privia Health Group (NASDAQ:PRVA) in a report issued on Friday,Benzinga reports. The firm currently has a $30.00 target price on the stock.

PRVA has been the subject of a number of other research reports. JMP Securities set a $29.00 price target on shares of Privia Health Group in a research note on Friday, February 28th. Stephens reiterated an “overweight” rating and set a $26.00 price target on shares of Privia Health Group in a research note on Thursday, January 2nd. Macquarie started coverage on shares of Privia Health Group in a research note on Monday, December 16th. They set an “outperform” rating and a $25.00 price target for the company. Piper Sandler upped their price objective on shares of Privia Health Group from $25.00 to $40.00 and gave the stock an “overweight” rating in a research report on Friday, February 28th. Finally, Canaccord Genuity Group upped their price objective on shares of Privia Health Group from $29.00 to $30.00 and gave the stock a “buy” rating in a research report on Friday, February 28th. One investment analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of $26.67.

Privia Health Group Price Performance

Shares of NASDAQ:PRVA opened at $23.34 on Friday. The stock has a market cap of $2.81 billion, a P/E ratio of 233.42, a P/E/G ratio of 3.47 and a beta of 0.85. The firm has a fifty day moving average price of $23.65 and a 200 day moving average price of $21.02. Privia Health Group has a 1-year low of $15.92 and a 1-year high of $26.04.

Hedge Funds Weigh In On Privia Health Group

A number of large investors have recently made changes to their positions in the stock. Quadrant Capital Group LLC increased its holdings in shares of Privia Health Group by 11.8% in the 4th quarter. Quadrant Capital Group LLC now owns 4,855 shares of the company’s stock valued at $95,000 after purchasing an additional 511 shares in the last quarter. Park Avenue Securities LLC increased its holdings in Privia Health Group by 3.8% during the 4th quarter. Park Avenue Securities LLC now owns 14,697 shares of the company’s stock valued at $287,000 after acquiring an additional 532 shares in the last quarter. PNC Financial Services Group Inc. increased its holdings in Privia Health Group by 8.0% during the 4th quarter. PNC Financial Services Group Inc. now owns 7,169 shares of the company’s stock valued at $140,000 after acquiring an additional 533 shares in the last quarter. First Horizon Advisors Inc. increased its holdings in Privia Health Group by 53.8% during the 4th quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock valued at $35,000 after acquiring an additional 632 shares in the last quarter. Finally, Summit Investment Advisors Inc. increased its holdings in Privia Health Group by 6.8% during the 4th quarter. Summit Investment Advisors Inc. now owns 10,673 shares of the company’s stock valued at $209,000 after acquiring an additional 678 shares in the last quarter. Hedge funds and other institutional investors own 94.48% of the company’s stock.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.